Nicox SA - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Nicox SA Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Nicox SA. The Group's principal activity is to develop nitric-oxide donating drugs targeting the therapeutic area. The Group offers biopharmaceutical therapeutics to treat ailments such as osteoarthritis, diabetes, inflammation and cardio metabolic diseases. The Group markets its products under the brand names Naproxcinod, NCX 4016 and NCX 6560. The Group also works in association with major pharmaceutical companies such as Pfizer, Merck and Group Ferrer. The Group operates in France.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report